首页> 外文期刊>Biochimica et biophysica acta. Molecular cell research >Chemotactic and proangiogenic role of calcium sensing receptor is linked to secretion of multiple cytokines and growth factors in breast cancer MDA-MB-231 cells
【24h】

Chemotactic and proangiogenic role of calcium sensing receptor is linked to secretion of multiple cytokines and growth factors in breast cancer MDA-MB-231 cells

机译:钙敏感受体的趋化和促血管生成作用与乳腺癌MDA-MB-231细胞中多种细胞因子和生长因子的分泌有关

获取原文
获取原文并翻译 | 示例
           

摘要

Breast cancer metastasis to the bone, potentially facilitated by chemotactic and angiogenic cytokines, contributes to a dramatic osteolytic effect associated with this invasive behavior. Based on the intrinsic ability of calcium sensing receptor (CaSR) to control hormonal secretion and considering its expression in the breast, we hypothesized that CaSR plays a chemotactic and proangiogenic role in highly invasive MDA-MB-231 breast cancer cells by promoting secretion of multiple cytokines. In this study, we show that MDA-MB-231 cells stimulated with R-568 calcimimetic and extracellular calcium secreted multiple cytokines and growth factors that induced endothelial cell migration and in vitro angiogenesis. These effects were dependent on the activity of CaSR as demonstrated by the inhibitory effect of either anti-CaSR blocking monoclonal antibodies or calcilytic NPS-2143. Moreover, CaSR knockdown prevented the proangiogenic effect of CaSR agonists. Importantly, CaSR promoted secretion of pleiotropic molecules like GM-CSF, EGF, MDC/CCL22, FGF-4 and IGEBP2, all known to be chemotactic mediators with putative angiogenic factor properties. In contrast, constitutive secretion of IL-6 and beta-NGF was attenuated by CaSR. In the case of normal mammary cells, secretion of IL-6 was stimulated by CaSR, whereas a constitutive secretion of RANTES, Angiogenin and Oncostatin M was attenuated by this receptor. Taken together, our results indicate that an altered secretion of chemotactic and proangiogenic cytokines in breast cancer cells is modulated by CaSR, which can be considered a potential target in the therapy of metastatic breast cancer. (C) 2014 Elsevier B.V. All tights reserved.
机译:趋化性和血管生成性细胞因子可能促进乳腺癌向骨的转移,从而导致与这种侵袭行为相关的戏剧性溶骨作用。基于钙敏感受体(CaSR)控制激素分泌的内在能力并考虑其在乳腺癌中的表达,我们假设CaSR通过促进多种分泌物的分泌在高侵袭性MDA-MB-231乳腺癌细胞中起趋化和促血管生成作用。细胞因子。在这项研究中,我们表明,用R-568拟钙剂和细胞外钙刺激的MDA-MB-231细胞分泌了多种诱导内皮细胞迁移和体外血管生成的细胞因子和生长因子。这些作用取决于CaSR的活性,如抗CaSR阻断性单克隆抗体或钙化NPS-2143的抑制作用所证明。此外,CaSR抑制可防止CaSR激动剂的促血管生成作用。重要的是,CaSR促进了多效性分子(如GM-CSF,EGF,MDC / CCL22,FGF-4和IGEBP2)的分泌,这些都是已知的趋化性介质,具有推定的血管生成因子特性。相比之下,CaSR减弱了IL-6和β-NGF的组成型分泌。对于正常的乳腺细胞,CaSR刺激IL-6的分泌,而该受体减弱RANTES,血管生成素和制瘤素M的组成型分泌。两者合计,我们的结果表明,CaSR可调节乳腺癌细胞中趋化和促血管生成细胞因子的分泌变化,CaSR可被认为是转移性乳腺癌治疗的潜在靶标。 (C)2014 Elsevier B.V.版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号